A recent study proposed the “FLAIR score,” which consists of five key indicators: ferritin levels, LDH levels, anti-MDA5 antibody grading, HRCT imaging score, and RPILD/non-RPILD, to predict mortality in patients with amyopathic dermatomyositis (ADM)-associated ILD (25). Here, IFIH1 is linked to dermatomyositis.